O-06: Schools as screen points for early-stage type 1 diabetes – EDENT1FI in Portugal
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von M Dingle und 26 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Type 1 diabetes (T1D) is a multifactorial autoimmune disease. Autoantibodies (Aab) are key markers of its early stages. EDENT1FI is a European initiative focused on screening pre-symptomatic T1D in children and adolescents.
Objectives
In Portugal, screens were conducted at health facilities, community events and schools. We aim to characterize adherence to T1D screening in schools, a learning and socialization environment where children and adolescents spend their day.
Methods
The clinical team presented the project to schools, provided informative documents and informed consent with an initial questionnaire to collect demographic data. After guardian consent, screening is scheduled at school. The screening requires a capillary blood sample and uses an ELISA kit for GAD, IA-2A and ZnT8. Positive samples are further tested for all four Aab (including IAA) in the same sample using LIPS, with venous confirmation if positive. Individuals with multiple Aab are referred to clinical follow-up, which includes metabolic staging (OGTT), CGM and psychological follow-up.
Results
Up to April 2026, 12.312 screenings were carried out, of which 47% were in 78 schools (62% public and 38% private), in children and adolescents aged 3 to 17 years, with a mean age of 10.2± 3.6, and 3.7% having a first-degree family T1D history. After confirmation of the venous test, 0.34% of individuals had two or more positive Aab (not different from the global sample) and were therefore classified as having early-stage T1D. All participants adhered in the follow-up protocol.
Conclusions
This screening methodology has proven to be very effective also in schools. The school environment improves family participation; participants are with their friends and peers, which provides security and a relaxed atmosphere. Identifying children and adolescents with T1D in the early-stage has enabled timely access to a staging and education program, opening new perspectives for treatment.
Zitieren
APA
Dingle, M., Coelho, R., Matos, D., Espada, F., Margalha, A., Castro, S., Luis, M., Soares, S., Antas, C., Afonso, M., Santos, R., Pereira, M., Fastré, A., Sousa, S., Covinhas, A., Almeida, I., Andrade, R., Silva, M., Ribeiro, R., …, & Consortium, E. (2026). O-06: Schools as screen points for early-stage type 1 diabetes – EDENT1FI in Portugal. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.006
Vancouver
Dingle M, Coelho R, Matos D, Espada F, Margalha A, Castro S, et al. O-06: Schools as screen points for early-stage type 1 diabetes – EDENT1FI in Portugal. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.006
BibTeX
@article{Dingle2026,
author = {Dingle, M and Coelho, R and Matos, D and Espada, F and Margalha, A and Castro, S and Luis, M and Soares, S and Antas, C and Afonso, M and Santos, R and Pereira, M and Fastré, A and Sousa, S and Covinhas, A and Almeida, I and Andrade, R and Silva, M and Ribeiro, R and Correia, I and Boavida, J and Vercauteren, J and Mathieu, C and Ziegler, A and Raposo, J and Team, Portuguese EDENT1FI and Consortium, EDENT1FI},
title = {O-06: Schools as screen points for early-stage type 1 diabetes – EDENT1FI in Portugal},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.006}
}
EUVIMED